-
1
-
-
0001284072
-
Anticomplementary factor in fresh yeast
-
Anticomplementary factor in fresh yeast. Pillemer L, Ecker EE, J Biol Chem 1941 137 139 142
-
(1941)
J Biol Chem
, vol.137
, pp. 139-142
-
-
Pillemer, L.1
Ecker, E.E.2
-
2
-
-
0005983828
-
Properdin system and immunity. II. Interaction of the properdin system with polysaccharides
-
10.1126/science.122.3169.545 13255887
-
Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Pillemer L, Schoenberg MD, Blum L, Wurz L, Science 1955 122 3169 545 549 10.1126/science.122.3169.545 13255887
-
(1955)
Science
, vol.122
, Issue.3169
, pp. 545-549
-
-
Pillemer, L.1
Schoenberg, M.D.2
Blum, L.3
Wurz, L.4
-
3
-
-
41149148624
-
Beta-glucans, history, and the present: Immunomodulatory aspects and mechanisms of action
-
10.1080/15476910802019045 18382858
-
Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. Novak M, Vetvicka V, J Immunotoxicol 2008 5 47 57 10.1080/15476910802019045 18382858
-
(2008)
J Immunotoxicol
, vol.5
, pp. 47-57
-
-
Novak, M.1
Vetvicka, V.2
-
4
-
-
65549091935
-
Glucans as biological response modifiers
-
10.2174/187153009787582423 19275682
-
Glucans as biological response modifiers. Novak M, Vetvicka V, Endocr Metab Immune Disord Drug Targets 2009 9 67 75 10.2174/187153009787582423 19275682
-
(2009)
Endocr Metab Immune Disord Drug Targets
, vol.9
, pp. 67-75
-
-
Novak, M.1
Vetvicka, V.2
-
6
-
-
28744441263
-
Natural and modified (1->3)-beta-D-glucans in health promotion and disease alleviation
-
10.1080/07388550500376166 16419618
-
Natural and modified (1->3)-beta-D-glucans in health promotion and disease alleviation. Zekovic DB, Kwiatkowski S, Vrvic MM, Jakovljevic D, Moran CA, Crit Rev Biotechnol 2005 25 205 230 10.1080/07388550500376166 16419618
-
(2005)
Crit Rev Biotechnol
, vol.25
, pp. 205-230
-
-
Zekovic, D.B.1
Kwiatkowski, S.2
Vrvic, M.M.3
Jakovljevic, D.4
Moran, C.A.5
-
7
-
-
84878798357
-
Beta(1-3)-D-glucan affects adipogenesis, wound healing and inflammation
-
10.1007/s13596-011-0024-4
-
beta(1-3)-D-glucan affects adipogenesis, wound healing and inflammation. Vetvicka V, Vetvickova J, Orient Pharm Exp Med 2011 11 169 175 10.1007/s13596-011-0024-4
-
(2011)
Orient Pharm Exp Med
, vol.11
, pp. 169-175
-
-
Vetvicka, V.1
Vetvickova, J.2
-
8
-
-
0002986082
-
(1-3)-β-D-Glucans as biological response modifiers: A review of structure-functional activity relationships
-
10.1016/0144-8617(95)00076-3
-
(1-3)-β-D-Glucans as biological response modifiers: a review of structure-functional activity relationships. Bohn JA, BeMiller JN, Carbohydr Polym 1995 28 1 3 14 10.1016/0144-8617(95)00076-3
-
(1995)
Carbohydr Polym
, vol.28
, Issue.1
, pp. 3-14
-
-
Bohn, J.A.1
Bemiller, J.N.2
-
9
-
-
15944378168
-
Immune recognition of fungal β-glucans
-
10.1111/j.1462-5822.2005.00505.x 15760447
-
Immune recognition of fungal β-glucans. Brown GD, Gordon S, Cell Microbiol 2005 7 471 479 10.1111/j.1462-5822.2005.00505.x 15760447
-
(2005)
Cell Microbiol
, vol.7
, pp. 471-479
-
-
Brown, G.D.1
Gordon, S.2
-
10
-
-
76949094767
-
The effects of beta-glucan on human immune and cancer cells
-
10.1186/1756-8722-2-25 19515245
-
The effects of beta-glucan on human immune and cancer cells. Chan GC, Chan WK, Sze DM, J Hematol Oncol 2009 2 25 10.1186/1756-8722-2-25 19515245
-
(2009)
J Hematol Oncol
, vol.2
, pp. 25
-
-
Chan, G.C.1
Chan, W.K.2
Sze, D.M.3
-
11
-
-
42949128589
-
Dietary modulation of immune function by beta-glucans
-
10.1016/j.physbeh.2007.11.045 18222501
-
Dietary modulation of immune function by beta-glucans. Volman JJ, Ramakers JD, Plat J, Physiol Behav 2008 94 276 284 10.1016/j.physbeh.2007.11.045 18222501
-
(2008)
Physiol Behav
, vol.94
, pp. 276-284
-
-
Volman, J.J.1
Ramakers, J.D.2
Plat, J.3
-
12
-
-
78751560494
-
Pathogen recognition by the innate immune system
-
10.3109/08830185.2010.529976 21235323
-
Pathogen recognition by the innate immune system. Kumar H, Kawai T, Akira S, Int Rev Immunol 2011 30 16 34 10.3109/08830185.2010.529976 21235323
-
(2011)
Int Rev Immunol
, vol.30
, pp. 16-34
-
-
Kumar, H.1
Kawai, T.2
Akira, S.3
-
13
-
-
27144540463
-
Are innate immune signaling pathways in plants and animals conserved?
-
10.1038/ni1253 16177805
-
Are innate immune signaling pathways in plants and animals conserved? Ausubel FM, Nat Immunol 2005 6 973 979 10.1038/ni1253 16177805
-
(2005)
Nat Immunol
, vol.6
, pp. 973-979
-
-
Ausubel, F.M.1
-
14
-
-
20744438481
-
Innate and acquired plasticity of the intestinal immune system
-
10.1007/s00018-005-5032-4 15971103
-
Innate and acquired plasticity of the intestinal immune system. Didierlaurent A, Simonet M, Sirard JC, Cell Mol Life Sci 2005 62 1285 1287 10.1007/s00018-005-5032-4 15971103
-
(2005)
Cell Mol Life Sci
, vol.62
, pp. 1285-1287
-
-
Didierlaurent, A.1
Simonet, M.2
Sirard, J.C.3
-
15
-
-
0038558248
-
Dectin-1 mediates the biological effects of beta-glucans
-
10.1084/jem.20021890 12719478
-
Dectin-1 mediates the biological effects of beta-glucans. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S, J Exp Med 2003 197 1119 1124 10.1084/jem.20021890 12719478
-
(2003)
J Exp Med
, vol.197
, pp. 1119-1124
-
-
Brown, G.D.1
Herre, J.2
Williams, D.L.3
Willment, J.A.4
Marshall, A.S.5
Gordon, S.6
-
16
-
-
23944442538
-
Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge
-
10.1124/jpet.105.085415 15976018
-
Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Deponti WK, Kalbfleisch JH, Ensley HE, Brown GD, Gordon S, Williams DL, J Pharmacol Exp Ther 2005 314 1079 1086 10.1124/jpet.105.085415 15976018
-
(2005)
J Pharmacol Exp Ther
, vol.314
, pp. 1079-1086
-
-
Rice, P.J.1
Adams, E.L.2
Ozment-Skelton, T.3
Gonzalez, A.J.4
Goldman, M.P.5
Lockhart, B.E.6
Barker, L.A.7
Breuel, K.F.8
Deponti, W.K.9
Kalbfleisch, J.H.10
Ensley, H.E.11
Brown, G.D.12
Gordon, S.13
Williams, D.L.14
-
17
-
-
0023077050
-
Specificity of membrane complement receptor type three (CR3) for beta-glucans
-
3040332
-
Specificity of membrane complement receptor type three (CR3) for beta-glucans. Ross GD, Cain JA, Myones BL, Newman SL, Lachmann PJ, Complement 1987 4 61 74 3040332
-
(1987)
Complement
, vol.4
, pp. 61-74
-
-
Ross, G.D.1
Cain, J.A.2
Myones, B.L.3
Newman, S.L.4
Lachmann, P.J.5
-
18
-
-
77953464750
-
(1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages
-
(1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. Kankkunen P, Teirila L, Rintahaka J, Alenius H, Wolff H, Matikainen S, J Immunol 2011 184 6335 6342
-
(2011)
J Immunol
, vol.184
, pp. 6335-6342
-
-
Kankkunen, P.1
Teirila, L.2
Rintahaka, J.3
Alenius, H.4
Wolff, H.5
Matikainen, S.6
-
19
-
-
0019378352
-
Glycan stimulation of macrophages in vitro
-
10.1016/0014-4827(81)90413-4 7447985
-
Glycan stimulation of macrophages in vitro. Seljelid R, Bögwald J, Lundwall A, Exp Cell Res 1981 131 121 129 10.1016/0014-4827(81)90413-4 7447985
-
(1981)
Exp Cell Res
, vol.131
, pp. 121-129
-
-
Seljelid, R.1
Bögwald, J.2
Lundwall, A.3
-
20
-
-
0029585440
-
Mitogenic activity of particulate yeast b-(1,)-D-glucan and its water-soluble derivates
-
10.1016/0141-8130(96)81839-3 8789333
-
Mitogenic activity of particulate yeast b-(1,)-D-glucan and its water-soluble derivates. Sandula J, Machnova E, Int J Biol Macromol 1995 17 323 327 10.1016/0141-8130(96)81839-3 8789333
-
(1995)
Int J Biol Macromol
, vol.17
, pp. 323-327
-
-
Sandula, J.1
Machnova, E.2
-
21
-
-
0028127061
-
A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients
-
10.1001/archsurg.1994.01420350102014 7979954
-
A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P, Arch Surg 1994 129 1204 1210 10.1001/archsurg.1994.01420350102014 7979954
-
(1994)
Arch Surg
, vol.129
, pp. 1204-1210
-
-
Babineau, T.J.1
Hackford, A.2
Kenler, A.3
Bistrian, B.4
Forse, R.A.5
Fairchild, P.G.6
Heard, S.7
Keroack, M.8
Caushaj, P.9
Benotti, P.10
-
22
-
-
0027986554
-
Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients
-
10.1097/00000658-199411000-00002 7979607
-
Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA, Ann Surg 1994 220 601 609 10.1097/00000658- 199411000-00002 7979607
-
(1994)
Ann Surg
, vol.220
, pp. 601-609
-
-
Babineau, T.J.1
Marcello, P.2
Swails, W.3
Kenler, A.4
Bistrian, B.5
Forse, R.A.6
-
23
-
-
0027367184
-
Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan)
-
8211583
-
Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). de Felippe JJ, Maciel FM, Soares AM, Mendes NF, Surg Gynecol Obstet 1993 177 383 8211583
-
(1993)
Surg Gynecol Obstet
, vol.177
, pp. 383
-
-
De Felippe, J.J.1
Maciel, F.M.2
Soares, A.M.3
Mendes, N.F.4
-
24
-
-
0024423872
-
Immunomodulation by orally administered beta-glucan in mice
-
10.1016/0192-0561(89)90130-6 2599714
-
Immunomodulation by orally administered beta-glucan in mice. Suzuki I, Hashimoto K, Ohno N, Tanaka H, Yadomae T, Int J Immunopharmacol 1989 11 761 769 10.1016/0192-0561(89)90130-6 2599714
-
(1989)
Int J Immunopharmacol
, vol.11
, pp. 761-769
-
-
Suzuki, I.1
Hashimoto, K.2
Ohno, N.3
Tanaka, H.4
Yadomae, T.5
-
25
-
-
3142702164
-
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models
-
10.4049/jimmunol.173.2.797 15240666
-
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD, J Immunol 2004 173 797 806 10.4049/jimmunol.173.2.797 15240666
-
(2004)
J Immunol
, vol.173
, pp. 797-806
-
-
Hong, F.1
Yan, J.2
Baran, J.T.3
Allendorf, D.J.4
Hansen, R.D.5
Ostroff, G.R.6
Xing, P.X.7
Cheung, N.K.8
Ross, G.D.9
-
26
-
-
0025164502
-
Effect of orally administered beta-glucan on macrophage function in mice
-
10.1016/0192-0561(90)90105-V 2272730
-
Effect of orally administered beta-glucan on macrophage function in mice. Suzuki I, Tanaka H, Kinoshita A, Oikawa S, Osawa M, Yadomae T, Int J Immunopharmacol 1990 12 675 684 10.1016/0192-0561(90)90105-V 2272730
-
(1990)
Int J Immunopharmacol
, vol.12
, pp. 675-684
-
-
Suzuki, I.1
Tanaka, H.2
Kinoshita, A.3
Oikawa, S.4
Osawa, M.5
Yadomae, T.6
-
27
-
-
77950289478
-
Effect of Biolex Beta-HP on phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats intoxicated by cyclophosphamide
-
21077449
-
Effect of Biolex Beta-HP on phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats intoxicated by cyclophosphamide. Wojcik R, Pol J Vet Sci 2010 13 181 188 21077449
-
(2010)
Pol J Vet Sci
, vol.13
, pp. 181-188
-
-
Wojcik, R.1
-
28
-
-
77954630630
-
Effect of Biolex β-HP on selected parameters of specific and non-specific humoral and cellular immunity in rats
-
Effect of Biolex β-HP on selected parameters of specific and non-specific humoral and cellular immunity in rats. Małaczewska J, Wójcik R, Jung L, Siwicki AK, Bull Vet Inst Pulawy 2010 54 75 80
-
(2010)
Bull Vet Inst Pulawy
, vol.54
, pp. 75-80
-
-
Małaczewska, J.1
Wójcik, R.2
Jung, L.3
Siwicki, A.K.4
-
29
-
-
0038368804
-
Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan
-
10.1016/S0008-8749(03)00061-3 12742376
-
Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan. Tsukada C, Yokoyama H, Miyaji C, Ishimoto Y, Kawamura H, Abo T, Cell Immunol 2003 221 1 5 10.1016/S0008-8749(03)00061-3 12742376
-
(2003)
Cell Immunol
, vol.221
, pp. 1-5
-
-
Tsukada, C.1
Yokoyama, H.2
Miyaji, C.3
Ishimoto, Y.4
Kawamura, H.5
Abo, T.6
-
30
-
-
16544391188
-
Orally-administered yeast β1,3-glucan Prophylactically protects against anthrax infection and cancer in mice
-
Orally-administered yeast β1,3-glucan Prophylactically protects against anthrax infection and cancer in mice. Vetvicka V, Terayama K, Mandeville R, Brousseau P, Kournikakis B, Ostroff G, J Am Nutraceutical Ass 2002 5 2 16 20
-
(2002)
J Am Nutraceutical Ass
, vol.5
, Issue.2
, pp. 16-20
-
-
Vetvicka, V.1
Terayama, K.2
Mandeville, R.3
Brousseau, P.4
Kournikakis, B.5
Ostroff, G.6
-
31
-
-
79959526149
-
Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived beta-glucans
-
10.1182/blood-2011-02-339812 21531981
-
Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived beta-glucans. Qi C, Cai Y, Gunn L, Ding C, Li B, Kloecker G, Qian K, Vasilakos J, Saijo S, Iwakura Y, Yannelli JR, Yan J, Blood 2011 117 6825 6836 10.1182/blood-2011-02-339812 21531981
-
(2011)
Blood
, vol.117
, pp. 6825-6836
-
-
Qi, C.1
Cai, Y.2
Gunn, L.3
Ding, C.4
Li, B.5
Kloecker, G.6
Qian, K.7
Vasilakos, J.8
Saijo, S.9
Iwakura, Y.10
Yannelli, J.R.11
Yan, J.12
-
32
-
-
41149133426
-
Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching
-
10.1124/jpet.107.133124 18171906
-
Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching. Adams EL, Rice PJ, Graves B, Ensley HE, Yu H, Brown GD, Gordon S, Monteiro MA, Papp-Szabo E, Lowman DW, Power TD, Wempe MF, Williams DL, J Pharmacol Exp Ther 2008 325 115 123 10.1124/jpet.107.133124 18171906
-
(2008)
J Pharmacol Exp Ther
, vol.325
, pp. 115-123
-
-
Adams, E.L.1
Rice, P.J.2
Graves, B.3
Ensley, H.E.4
Yu, H.5
Brown, G.D.6
Gordon, S.7
Monteiro, M.A.8
Papp-Szabo, E.9
Lowman, D.W.10
Power, T.D.11
Wempe, M.F.12
Williams, D.L.13
-
33
-
-
79955537225
-
Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'
-
10.1038/nature10071 21525931
-
Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Goodridge HS, Reyes CN, Becker CA, Katsumoto TR, Ma J, Wolf AJ, Bose N, Chan AS, Magee AS, Danielson ME, Weiss A, Vasilakos JP, Underhill DM, Nature 2011 472 471 475 10.1038/nature10071 21525931
-
(2011)
Nature
, vol.472
, pp. 471-475
-
-
Goodridge, H.S.1
Reyes, C.N.2
Becker, C.A.3
Katsumoto, T.R.4
Ma, J.5
Wolf, A.J.6
Bose, N.7
Chan, A.S.8
Magee, A.S.9
Danielson, M.E.10
Weiss, A.11
Vasilakos, J.P.12
Underhill, D.M.13
-
34
-
-
69249228499
-
Effect of β-1,3/1,6-D-glucan on the phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats
-
Effect of β-1,3/1,6-D-glucan on the phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats. Wójcik R, Janowska E, Malaczewska J, Siwicki AK, Bull Vet Inst Pulawy 2009 53 241 246
-
(2009)
Bull Vet Inst Pulawy
, vol.53
, pp. 241-246
-
-
Wójcik, R.1
Janowska, E.2
Malaczewska, J.3
Siwicki, A.K.4
-
35
-
-
84881356857
-
The effectiveness of natural and synthetic immunomodulators in the treatment of inflammatory bowel disease in dogs
-
10.1556/AVet.2013.015 23921342
-
The effectiveness of natural and synthetic immunomodulators in the treatment of inflammatory bowel disease in dogs. Rychlik A, Nieradka R, Kander M, Nowicki M, Wdowiak M, Kolodziejska-Sawerska A, Acta Vet Hung 2013 61 297 308 10.1556/AVet.2013.015 23921342
-
(2013)
Acta Vet Hung
, vol.61
, pp. 297-308
-
-
Rychlik, A.1
Nieradka, R.2
Kander, M.3
Nowicki, M.4
Wdowiak, M.5
Kolodziejska-Sawerska, A.6
-
36
-
-
0025864320
-
Psychological stress and susceptibility to the common cold
-
10.1056/NEJM199108293250903 1713648
-
Psychological stress and susceptibility to the common cold. Cohen S, Tyrrell DA, Smith AP, N Engl J Med 1991 325 606 612 10.1056/NEJM199108293250903 1713648
-
(1991)
N Engl J Med
, vol.325
, pp. 606-612
-
-
Cohen, S.1
Tyrrell, D.A.2
Smith, A.P.3
-
37
-
-
85046520814
-
Negative life events, perceived stress, negative affect, and susceptibility to the common cold
-
8421249
-
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. Cohen S, Tyrrell DA, Smith AP, J Pers Soc Psychol 1993 64 131 140 8421249
-
(1993)
J Pers Soc Psychol
, vol.64
, pp. 131-140
-
-
Cohen, S.1
Tyrrell, D.A.2
Smith, A.P.3
-
38
-
-
84890553236
-
Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body's defence against pathogens: A double-blind, randomized, placebo-controlled, multicentric study in healthy subjects
-
Epub ahead of print
-
Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body's defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects. Auinger A, Riede L, Bothe G, Busch R, Gruenwald J, Eur J Nutr 2013 Epub ahead of print
-
(2013)
Eur J Nutr
-
-
Auinger, A.1
Riede, L.2
Bothe, G.3
Busch, R.4
Gruenwald, J.5
-
39
-
-
84890549197
-
A double-blind, randomized, placebo-controlled nutritional study using an insoluble yeast beta-glucan to improve the immune defense system
-
10.4236/fns.2012.36100
-
A double-blind, randomized, placebo-controlled nutritional study using an insoluble yeast beta-glucan to improve the immune defense system. Graubaum H-J, Busch R, Stier H, Gruenwald J, Food Nutr Sci 2012 3 738 746 10.4236/fns.2012.36100
-
(2012)
Food Nutr Sci
, vol.3
, pp. 738-746
-
-
Graubaum, H.-J.1
Busch, R.2
Stier, H.3
Gruenwald, J.4
-
40
-
-
65449168381
-
Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans
-
10.1016/j.nutres.2009.03.002 19410976
-
Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans. Kohl A, Gogebakan O, Mohlig M, Osterhoff M, Isken F, Pfeiffer AF, Weickert MO, Nutr Res 2009 29 248 254 10.1016/j.nutres.2009.03.002 19410976
-
(2009)
Nutr Res
, vol.29
, pp. 248-254
-
-
Kohl, A.1
Gogebakan, O.2
Mohlig, M.3
Osterhoff, M.4
Isken, F.5
Pfeiffer, A.F.6
Weickert, M.O.7
-
41
-
-
0032819217
-
Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group
-
10.1001/archsurg.134.9.977 10487593
-
Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE, Arch Surg 1999 134 977 983 10.1001/archsurg.134.9.977 10487593
-
(1999)
Arch Surg
, vol.134
, pp. 977-983
-
-
Dellinger, E.P.1
Babineau, T.J.2
Bleicher, P.3
Kaiser, A.B.4
Seibert, G.B.5
Postier, R.G.6
Vogel, S.B.7
Norman, J.8
Kaufman, D.9
Galandiuk, S.10
Condon, R.E.11
-
42
-
-
68249142919
-
Randomized phase II clinical trials of Wellmune WGP for immune support during cold and flu season
-
Randomized phase II clinical trials of Wellmune WGP for immune support during cold and flu season. Feldman S, Schwartz HI, Kalman DS, Mayers A, Kohrman HM, Clemens R, Krieger D, J Appl Res 2009 9 30 42
-
(2009)
J Appl Res
, vol.9
, pp. 30-42
-
-
Feldman, S.1
Schwartz, H.I.2
Kalman, D.S.3
Mayers, A.4
Kohrman, H.M.5
Clemens, R.6
Krieger, D.7
-
43
-
-
72249095793
-
Effect of beta 1,3/1,6 glucan on upper respiratory tract infection symptoms and mood state in marathon athlets
-
24149590
-
Effect of beta 1,3/1,6 glucan on upper respiratory tract infection symptoms and mood state in marathon athlets. Talbott S, Talbott J, J Sports Sci Med 2009 8 509 515 24149590
-
(2009)
J Sports Sci Med
, vol.8
, pp. 509-515
-
-
Talbott, S.1
Talbott, J.2
-
44
-
-
77950615734
-
Beta 1,3/1,6 glucan decreases upper respiratory tract infection symptoms and improves psychological well-being in moderate to highly-stressed subjects
-
Beta 1,3/1,6 glucan decreases upper respiratory tract infection symptoms and improves psychological well-being in moderate to highly-stressed subjects. Talbott S, Talbott J, Agro Food Industry Hi-Tech 2010 21 21 24
-
(2010)
Agro Food Industry Hi-Tech
, vol.21
, pp. 21-24
-
-
Talbott, S.1
Talbott, J.2
-
45
-
-
84900435652
-
Beta-glucan supplement reduces URTIs (Upper Respiratory Tract Infections) and improves mood state in healthy stressed subjects
-
Beta-glucan supplement reduces URTIs (Upper Respiratory Tract Infections) and improves mood state in healthy stressed subjects. Talbott S, Talbott J, Cox D, FASEB J 2010 24 922
-
(2010)
FASEB J
, vol.24
, pp. 922
-
-
Talbott, S.1
Talbott, J.2
Cox, D.3
-
46
-
-
84885771707
-
Baker's yeast beta-glucan supplementation increases monocytes and cytokines post-exercise: Implications for infection risk?
-
10.1017/S0007114512001407 22575076
-
Baker's yeast beta-glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk? Carpenter KC, Breslin WL, Davidson T, Adams A, McFarlin BK, Br J Nutr 2013 109 3 478 486 10.1017/S0007114512001407 22575076
-
(2013)
Br J Nutr
, vol.109
, Issue.3
, pp. 478-486
-
-
Carpenter, K.C.1
Breslin, W.L.2
Davidson, T.3
Adams, A.4
McFarlin, B.K.5
-
47
-
-
84860620037
-
Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections
-
Epub ahead of print
-
Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections. Fuller R, Butt H, Noakes PS, Kenyon J, Yam TS, Calder PC, Nutrition 2012 Epub ahead of print
-
(2012)
Nutrition
-
-
Fuller, R.1
Butt, H.2
Noakes, P.S.3
Kenyon, J.4
Yam, T.S.5
Calder, P.C.6
-
48
-
-
84876334060
-
Baker's yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women
-
10.1080/07315724.2012.10720441 23378458
-
Baker's yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women. Talbott SM, Talbott JA, J Am Coll Nutr 2012 31 295 300 10.1080/07315724.2012.10720441 23378458
-
(2012)
J Am Coll Nutr
, vol.31
, pp. 295-300
-
-
Talbott, S.M.1
Talbott, J.A.2
-
49
-
-
33644829209
-
Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers
-
10.1111/j.1365-2249.2005.02962.x 16367935
-
Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Lehne G, Haneberg B, Gaustad P, Johansen PW, Preus H, Abrahamsen TG, Clin Exp Immunol 2006 143 65 69 10.1111/j.1365-2249.2005.02962.x 16367935
-
(2006)
Clin Exp Immunol
, vol.143
, pp. 65-69
-
-
Lehne, G.1
Haneberg, B.2
Gaustad, P.3
Johansen, P.W.4
Preus, H.5
Abrahamsen, T.G.6
-
50
-
-
84900442303
-
EFSA panel on dietetic products, nutrition and allergies (NDA): Scientific opinion on the substantiation of a health claim related to Yestimun® and immune responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006
-
EFSA
-
EFSA panel on dietetic products, nutrition and allergies (NDA): scientific opinion on the substantiation of a health claim related to Yestimun® and immune responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA, EFSA J 2010 8 11
-
(2010)
EFSA J
, vol.8
, pp. 11
-
-
-
51
-
-
84928109268
-
EFSA panel on dietetic products, nutrition and allergies (NDA): Scientific opinion on the substantiation of a health claim related to Yestimun® and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
-
EFSA
-
EFSA panel on dietetic products, nutrition and allergies (NDA): scientific opinion on the substantiation of a health claim related to Yestimun® and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA, EFSA Journal 2013 11 12
-
(2013)
EFSA Journal
, vol.11
, pp. 12
-
-
-
54
-
-
26044463239
-
Looking for immunotolerance: A case of allergy to baker's yeast (Saccharomyces cerevisiae)
-
16285232
-
Looking for immunotolerance: a case of allergy to baker's yeast (Saccharomyces cerevisiae). Pajno GB, Passalacqua G, Salpietro C, Vita D, Caminiti L, Barberio G, Eur Ann Allergy Clin Immunol 2005 37 271 272 16285232
-
(2005)
Eur Ann Allergy Clin Immunol
, vol.37
, pp. 271-272
-
-
Pajno, G.B.1
Passalacqua, G.2
Salpietro, C.3
Vita, D.4
Caminiti, L.5
Barberio, G.6
-
55
-
-
85078379445
-
Scientific Opinion on the safety of 'yeast beta-glucans' as a Novel Food ingredient
-
EFSA Panel on Dietetic Products NaAN [2122
-
Scientific Opinion on the safety of 'yeast beta-glucans' as a Novel Food ingredient. EFSA Panel on Dietetic Products NaAN, EFSA J 2011 9 2137 [2122 pp.]
-
(2011)
EFSA J
, vol.9
, pp. 2137
-
-
-
56
-
-
34547127390
-
Toxicological assessment of a particulate yeast (1,3/1,6)-beta-D-glucan in rats
-
10.1016/j.fct.2007.03.013 17493735
-
Toxicological assessment of a particulate yeast (1,3/1,6)-beta-D-glucan in rats. Babicek K, Cechova I, Simon RR, Harwood M, Cox DJ, Food Chem Toxicol 2007 45 1719 1730 10.1016/j.fct.2007.03.013 17493735
-
(2007)
Food Chem Toxicol
, vol.45
, pp. 1719-1730
-
-
Babicek, K.1
Cechova, I.2
Simon, R.R.3
Harwood, M.4
Cox, D.J.5
-
57
-
-
0018612504
-
Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan
-
10.1002/ijc.2910240613 397198
-
Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Di Luzio NR, Williams DL, McNamee RB, Edwards BF, Kitahama A, Int J Cancer 1979 24 773 779 10.1002/ijc.2910240613 397198
-
(1979)
Int J Cancer
, vol.24
, pp. 773-779
-
-
Di Luzio, N.R.1
Williams, D.L.2
McNamee, R.B.3
Edwards, B.F.4
Kitahama, A.5
-
58
-
-
0029097460
-
Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae
-
Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae. Williams DL, Mueller A, Browder W, J Endotoxin Res 1995 2 203 208
-
(1995)
J Endotoxin Res
, vol.2
, pp. 203-208
-
-
Williams, D.L.1
Mueller, A.2
Browder, W.3
|